Sponsor Deadline
Posted: 4/5/2022

Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to solicit applications for the Pediatric Immunotherapy Network (PIN). The overall goal of this FOA is to establish a collaborative network consisting of investigators with relevant expertise to develop and advance novel translational immunotherapy approaches for children and adolescents with solid tumors including brain tumors. This FOA solicits U01 applications for discrete research projects that address relevant research opportunities focused on pediatric solid tumors (e.g., mechanisms of immune evasion, development of pre-clinical models, discovery and validation of novel therapeutic targets, development of novel pediatric immunotherapy agents and treatment approaches such as cancer vaccines, cellular therapy, and combinations with immunotherapy agents. Successful applicants will become members of the Pediatric Immunotherapy Network (PIN), which will address current challenges in pediatric cancer immunotherapy and accelerate the pace at which effective immunotherapies are realized for pediatric solid tumors.


  • Letter of Intent Due Date(s): August 27, 2022

  • Application Due Date: Sep 27, 2022

RFA-CA-22-016 Expiration Date September 28, 2022

Amount Description

Application budgets may not exceed $450,000 in direct costs (excluding sub-award F&A costs) per year and must reflect the actual needs of the proposed project.

The maximum project period is 5 years.

Funding Type